Changes in heregulin β1 (HRGβ1) signaling after inhibition of ErbB-2 expression in a human breast cancer cell line

Molecular and Cellular Endocrinology

Volumn 138, Issue 1-2, 1998, Pages 163-171

  Yoo, Joo Yeon ^a,c   Hamburger, Anne W ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antisense; Breast cancer; Cellular proliferation; Differentiation; erbB2; Heregulin; Signal transduction

Indexed keywords

CELL DNA; COMPLEMENTARY DNA; NEU DIFFERENTIATION FACTOR; ANTISENSE OLIGONUCLEOTIDE; CARRIER PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCOPROTEIN; HEREGULIN BETA1; PRIMER DNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; DNA TRANSFECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; KINETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTO ONCOGENE;

BASE SEQUENCE; CARRIER PROTEINS; CELL DIVISION; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; GLYCOPROTEINS; HUMANS; KINETICS; NEUREGULIN-1; OLIGONUCLEOTIDES, ANTISENSE; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032536612     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00004-5     Document Type: Article

References (47)

1. Aviezer, D., Yajon, A., 1994. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin binding EGF-like growth factor but not by EGF. Proc. Natl. Acad. Sci. USA 91, 12173-12177.
2. Bacus, S.S., Huberman, E., Chin, D., Kiguchi, K., Simpson, S., Lippman, M., Lupu, R., 1992a. A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells. Cell Growth Differ. 3, 401-411.
3. Bacus, S.S., Stancovski, I., Huberman, E., Chin, D., Hurwirtz, E., Mills, G. B., Ullrich, A., Sela, M., Yarden, Y., 1992b. Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells. Cancer Res. 52, 2580-2589.
4. Bacus, S.S., Gudkov, A.V., Zelnick, C.R., Chin, D., Stern, R., Stancovski, I., Peles, E., Ben-Baruch, N., Farbstein, H., Lupu, R., Wen, D., Sela, M., Yarden, Y., 1993. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1:implication for mammary tumors. Cancer Res. 53, 5251-5261.
5. Batzer, A.G., Rotin, D., Urena, J.M., Skolnik, E.Y., Schlessinger, J., 1994. Hierachy of binding sites for Grb2 and She on the epidermal growth factor receptor. Mol. Cell. Biol. 14, 5192-5201.
6. Beerli, R.R., Graus-Porta, D., Woods-Cook, K., Chen, X., Yarden, Y., Hynes, N.E., 1995. Neu differentiation factor activation of erbB3 and erbB4 is cell specific and displays a differential requirement for erbB2. Mol. Cell. Biol. 15, 6496-6505.
7. Carraway, K.L., Sliwkowski, M.X., Akita, R., Platko, J.V., Guy, P.M., Nuijens, A, Diamonti, A.J., Vandlen, R.L., Cantley, L.C., Cerione, R.A, 1994. The erbB3 gene product is a receptor for heregulin. J. Biol. Chem. 269, 14303-14306.
8. Carraway, K.L., Soltoff, S.P., Diamonti, A.J., Cantley, L.C., 1995. Heregulin stimulates mitogenesis and Ptdins 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3. J. Biol. Chem. 270, 7111-7116.
9. Cheatham, B., Vlahos, C.J., Cheatham, L., Wang, L., Blenis, J., Kahn, C.R., 1994. Phosphatidyl-inositol 3-kinase activation is required for stimulaton of pp70 S6 kinase, DNA synthesis, and glucose transport translocation. Mol. Cell. Biol. 14, 4902-4911.
10. Chen, X, Levkowitz, G., Tzahar, E., Karunagaran, D., Lavi, S., Ben-Baruch, N., Leitner, O., Ratzkin, B.J., Bacus, S.S., Yarden, Y., 1996. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB3 and ErbB4. J. Biol. Chem. 271, 7620-7629.
11. Coussens, L., Yang-Feng, T.L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeburg, P.H., Libermann, T.A., Schlessinger, J., Francke, U., Levinson, A., Ullrich, A., 1985. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230, 1132-1138.
12. Elledge, R.M., McGuire, W.L., Osborne, C.K., 1992. Prognostic factors in breast cancer. Semin. Oncol. 19, 244-253.
13. Fiddes, R.J., Janes, P.W., Sanderson, G.M., Sivertsen, S.P., Sutherland, R.L., Daly, R.J., 1995. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells. Cell Growth Differ. 6, 1567-1577.
14. Fiore, P.P., Pierce, J.H., Kraus, M.H., Segatto, O., King, C.R., Aaronson, S.A., 1987. ErbB2 is apotent oncogene when overexpressed in NIH/3T3 cells. Science 237, 178-182.
15. Goldman, R.R., Ben-Levy, R., Peles, E., Yarden, Y., 1990. Heterodimerization of the erbB1 and erbB2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry 29, 11024-11028.
16. Graus-Porta, D., Beerli, R.R., Hynes, N.E., 1995. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol. Cell. Biol. 15, 1182-1191.
17. Gullick, W.J., 1991. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br. Med. Bull. 47, 87-98.
18. erbB2. Science 256, 1205-1210.
19. erbB2. J. Biol. Chem. 268, 2924-2931.
20. Jones, F.E., Jerry, D.J., Guarino, B.C., Andrews, G.C., Stern, D.F., 1996. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloaveoli. Cell Growth Differ. 7, 1031-1038.
21. Karunagaran, D., Tzahar, E., Beerli, R.R., Chen, X., Graus-Porta, D., Ratzkin, B. J., Segar, R., Hynes, N.E., Yarden, Y., 1996. ErbB-2 is a common signaling subunit of NDF- and EGF-receptors: implications for breast cancer. EMBO J. 15, 254-264.
22. Kim, H.-H., Sierke, S.L., Koland, J.G., 1994. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB-3 gene product. J. Biol. Chem. 269, 24747-24755.
23. King, C.R., Borrello, I., Bellot, F., Comoglio, P., Schlessinger, J., 1988. EGF binding to its receptor triggers a rapid phosphorylation of the erbB-2 protein in the mammary tumor cell line SKBR-3. EMBO J7, 1647-1651.
24. Kraus, M.H., Fedi, P., Starks, V., Muraro, R., Aaronson, S.A., 1993. Demonstration of ligand signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells. Proc. Natl. Acad. Sci. USA 90, 2900-2904.
25. Lemoine, N.R., Barnes, D.M., Hollywood, D.P., Hughes, C.M., Smith, P., Dublin, E., Prigent, S. A., Gullick, W.J., Hurst, H.C., 1992. Expression of the ERBB3 gene product in breast cancer. Br. J. Cancer 66, 1116-1121.
26. Lupu, R., Colomer, R., Kannan, B., Lippman, M.E., 1992. Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses. Proc. Natl. Acad. Sci. USA 89, 2287-2291.
27. Marte, B.M., Jeschke, M., Graus-Porta, D., Taverna, D., Hofer, P., Groner, B., Yarden, Y., Hynes, N.E., 1995. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epitheliual cells. Mol. Endocrinol. 9, 14-23.
28. Peles, E., Bacus, S.S., Koski, R.A, Lu, H.S., Wen, D., Ogden, S.G., Levy, R.B., Yarden, Y., 1992. Isolation of the Neu/HER-2 stimulatory ligand:a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69, 205-216.
29. Peles, E., Ben-Levy, R., Tzahar, E., Liu, N., Wen, D., Yarden, Y., 1993. Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2. EMBO J. 12, 961-971.
30. Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Segar, R., Ratzkin, B. J., Sela, M., Yarden, Y., 1996. Diversification of neu differentiation factor and epidermal growth signaling by combinational receptor interactions. EMBO J. 15, 2452-2467.
31. erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA 90, 1746-1750.
32. erbB-4. Nature 366, 473-475.
33. Ram, T.G., Kokeny, K.E., Dilts, C.A., Ethier, S.P., 1995. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-1 in human mammary epithelial cells. J. Cell. Physiol. 163, 589-596.
34. Ricci, A, Lanfrancone, L., Chiari, R., Belardo, G., Pertica, C., Natali, P.G., Pelicci, P.G., Segatto, O., 1995. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase. Oncogene 11, 1519-1529.
35. Riese II, D.J., van Raaij, T.M., Pbwman, G.D., Andrews, G.C., Stern, D.F., 1995. Cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol. 15, 5770-5776.
36. Sainsbury, J.R., Farndon, J.R., Needham, G.K., Maludm, A.J., Harris, A.L., 1987. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1, 1398-1402.
37. Sasaoka, T., Langlois, W.J., Leitner, J.W., Draznin, B., Olefsky, J.M., 1994a. The signaling pathway coupling epidermal growth factor receptors to activation of p21 ras. J. Biol. Chem. 269, 32621-32625.
38. Segatto, O., Pelicci, G., Giuli, S., Digiesi, G., Di Fiore, P.P., McGlade, J., Pawson, T., Pelicci, P.G., 1993. She products are substrates of erbB-2 kinase. Oncogene 8, 2105-2112.
39. Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A, McGuire, W.L., 1987. Human breast cancer: correlation of relapse survival with amplification of the HER-2/neu oncogene. Science 235, 177-182.
40. Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levin, W.J., Stuart, S.G., Udove, J., Ullrich, A., Press, M.F., 1989. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 244, 707-712.
41. Slikowski, M.X, Schaefer, G., Akita, R.W., Lofgren, J.A., Fitzpatrik, V.D., Fendly, B.M., Cerione, R.A., Vandlen, R.L., Carraway III, K.L., 1994. Coexpression of erbB-2 and erbB-3 proteins reconstitutes a high affnity receptor for heregulin. J. Biol. Chem. 269, 14661-14665.
42. Soltoff, S.P., Carraway III, K.L., Prigent, S.A., Gullick, W.G., Cantley, L.C., 1994. ErbB3 is involved in the activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol. 14, 3550-3558.
43. Ullrich, A, Schlessinger, J., 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-212.
44. Vaughn, J.P., Iglehart, J.D., Demirdji, S., Davis, P., Babiss, L.E., Caruthers, M.H., Marks, J.R., 1995. Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay. Proc. Natl. Acad. Sci. USA 92, 8338-8342.
45. Watanabe, T., Shintani, A., Nakata, M., Shing, Y., Folkman, J., Igarashi, K., Sasada, R., 1994. Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction. J. Biol. Chem. 269, 9966-9973.
46. Wen, D.E., Peles, E., Cupples, R., Suggs, S., Bacus, S.S., Luo, Y., Trail, G., Hu, S., Silbiger, S., Levy, R.B., Koski, R., Lu, H.S., Yarden, Y., 1992. Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 69, 559-572.
47. Yang, Y., Spitzer, D., Meyer, D., Sachs, M., Neimann, C., Hartmann, G., Weider, K.M., Birchmeier, C., Birchmeier, W., 1995. Sequential requirement of hepatocyte growth factor and heregulin in the morphogenesis and differentiation of the mammary gland. J. Cell. Biol. 131, 215-226.